Richard Olney Clinician Scientist Development Award in ALS Grant

Richard Olney Clinician Scientist Development Award in ALS Grant

Status: ACTIVE
Funder: American Academy Of Neurology Institute
Amount: Up to US $240,000
Last Updated: June 18, 2025

Summary

The Richard Olney Clinician Scientist Development Award in ALS, offered by the American Academy of Neurology, supports early career investigators with $75,000 annually for three years and a $5,000 stipend for education. This award emphasizes the significance of clinical research in ALS, encouraging diversity and inclusiveness within the research community. Eligible candidates must hold an MD or equivalent degree and be AAN members, with residency or PhD completion within the last seven years.

Overview

This award recognizes the importance of good clinical research and encourages early career investigators in clinical studies in ALS. This award will consist of a commitment of $75,000 per year for three years, plus a $5,000 per year stipend to support education and research-related costs for a total of $240,000. The American Academy of Neurology is firmly committed to embracing the diversity among our members, applicants, and reviewers and affirms the importance of equity and inclusiveness within the AAN research program.

Eligibility

You can learn more about this opportunity by visiting the funder's website. Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $80,000 annually.For the purpose of this scholarship, research is defined as “patient-oriented research conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurologic disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.Recipient must be an AAN member interested in an academic career in neurologic research with a MD, PhD equivalent doctoral-level clinical degree who has completed residency or a PhD no more than 7 years prior to the beginning of this award (July 1, 2025). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency. Applicants at accredited US and international institutions are eligible. You must be a member of this organization to apply for this award - become a member.